EyePoint Pharmaceuticals, Inc. (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

5.05

-0.37 (-6.83%)

At close: Apr 1, 2025, 4:00 PM

5.18

+0.13 (2.57%)

After-hours: Apr 1, 2025, 5:00 PM EDT

EyePoint Pharmaceuticals Market Cap

EyePoint Pharmaceuticals has a market cap or net worth of $347.08 million as of April 1, 2025. Its market cap has decreased by -67.96% in one year.

Market Cap

347.08M

Enterprise Value

-1.42M

1-Year Change

-67.96%

Ranking

#3107

Market Cap Chart

Since January 27, 2005, EyePoint Pharmaceuticals's market cap has decreased from $388.60M to $347.08M, a decrease of -10.68%. That is a compound annual growth rate of -0.56%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	372.50M	-26.75%
Dec 31, 2024	508.50M	-37.68%
Dec 29, 2023	816.00M	583.99%
Dec 30, 2022	119.30M	-66.13%
Dec 31, 2021	352.20M	273.09%
Dec 31, 2020	94.40M	-43.68%
Dec 31, 2019	167.60M	-6.53%
Dec 31, 2018	179.30M	266.67%
Dec 29, 2017	48.90M	-16.27%
Dec 30, 2016	58.40M	-58.82%
Dec 31, 2015	141.80M	17.58%
Dec 31, 2014	120.60M	12.71%
Dec 31, 2013	107.00M	279.43%
Dec 31, 2012	28.20M	22.08%
Dec 30, 2011	23.10M	-75.61%
Dec 31, 2010	94.70M	44.14%
Dec 31, 2009	65.70M	281.98%
Dec 31, 2008	17.20M	-70.19%
Dec 31, 2007	57.70M	-25.93%
Dec 29, 2006	77.90M	-62.73%
Dec 30, 2005	209.00M	-46.22%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	738.61B
UnitedHealth Group	472.03B
Johnson & Johnson	394.52B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	225.40B

Market Cap Rankings